Inhibition of APE1 redox function appears to be a better strategy as APE1 inhibitors with multi-targeting property not only blocks VEGF production, but also reduces inflammatory reaction that also contributes to AMD development. This evidence concerns the gene APEX1 and age-related macular degeneration.